Exploring the causal relationship and molecular mechanisms between Methyl-4-hydroxybenzoic acid (MEP) and Alzheimer’s disease: a mendelian randomization, multi-omics, and network toxicology approach
Toxicology Research · 05.07.2025 · 14 (4)
DOI: 10.1093/toxres/tfaf113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicology Research, online erschienen am 06.08.2025. Verfasst von Hong Gong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, The Affiliated Hospital of Yunnan University, 176 Qingnian Road, Kunming, Yunnan 650200, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
The pathogenesis of Alzheimer’s disease remains incompletely understood. Methyl-4-hydroxybenzoic acid, a common chemical additive, may play a role, though its mechanisms are unclear. This research investigated the potential causal link between Methyl-4-hydroxybenzoic acid and Alzheimer’s disease and examined underlying molecular mechanisms. Mendelian randomization analysis evaluated causality, using Cochran’s Q test, the Mendelian Randomization-Egger intercept test, and Mendelian Randomization Pleiotropy RESidual Sum and Outlier to assess heterogeneity and sensitivity. Methyl-4-hydroxybenzoic acid targets were identified through multiple databases, and a related target library was constructed using Weighted Gene Co-expression Network Analysis, differential gene expression analysis, and the Genecards database. A Protein–Protein Interaction network identified core genes, validated by molecular docking. Transcriptomic analysis and single-cell expression data explored cell-type-specific expression patterns. Results showed a significant positive causal association between Methyl-4-hydroxybenzoic acid and Alzheimer’s disease. We identified 198 Methyl-4-hydroxybenzoic acid targets, with 99 genes associated with both Methyl-4-hydroxybenzoic acid and Alzheimer’s disease. Six core genes (EGFR, ESR1, MAPK3, MMP9, PTGS2, TP53) were pinpointed. Functional enrichment implicated neuronal signaling, inflammation, and metabolism. Multi-omics and single-cell analyses revealed differential expression of core genes in key brain regions. Molecular docking confirmed stable interactions between Methyl-4-hydroxybenzoic acid and these proteins. This research confirms a causal relationship between Methyl-4-hydroxybenzoic acid and Alzheimer’s disease, revealing potential molecular mechanisms and core gene functions, offering insights into pathogenesis and therapeutic targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, The Affiliated Hospital of Yunnan University, 176 Qingnian Road, Kunming, Yunnan 650200, China.
- School of Health Sciences, Dehong Vocational College, 11 Yingshui Road, Mangshi, Dehong Prefecture, Yunnan 678400, China.
- Medical insurance office, Yunnan Provincial Hospital of Traditional Chinese Medicine, 120 Guanghua Street, Kunming, Yunnan 650021, China.
- Department of Oncology, The First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, Yunnan 650032, China.
ORCID-Profile: Jian Huang
Zitieren
APA
Gong, H., Li, J., Pu, R., & Huang, J. (2025). Exploring the causal relationship and molecular mechanisms between Methyl-4-hydroxybenzoic acid (MEP) and Alzheimer’s disease: a mendelian randomization, multi-omics, and network toxicology approach. Toxicology Research, 14(4). https://doi.org/10.1093/toxres/tfaf113
Vancouver
Gong H, Li J, Pu R, Huang J. Exploring the causal relationship and molecular mechanisms between Methyl-4-hydroxybenzoic acid (MEP) and Alzheimer’s disease: a mendelian randomization, multi-omics, and network toxicology approach. Toxicology Research. 2025;14(4). doi:10.1093/toxres/tfaf113
BibTeX
@article{Gong2025,
author = {Gong, Hong and Li, Jiayu and Pu, Rong and Huang, Jian},
title = {Exploring the causal relationship and molecular mechanisms between Methyl-4-hydroxybenzoic acid (MEP) and Alzheimer’s disease: a mendelian randomization, multi-omics, and network toxicology approach},
journal = {Toxicology Research},
year = {2025},
volume = {14},
number = {4},
doi = {10.1093/toxres/tfaf113}
}
EUVIMED